XKRX
024720
Market cap240mUSD
Oct 08, Last price
9,400.00KRW
1D
1.40%
1Q
12.04%
Jan 2017
-72.11%
IPO
186.41%
Name
Kolmar Korea Holdings Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Kolmar Korea Holdings Co., Ltd. is engaged in the manufacturing and global distribution of cosmetics, pharmaceutical products, and nutritional supplements, serving markets both within South Korea and internationally. Its comprehensive range of beauty offerings includes skincare, makeup, haircare, body care, and products designed for infants, alongside specialized functional cosmetics and fragrances. Furthermore, the company provides over-the-counter medications and dietary aids. Founded in 1990, its main corporate headquarters are situated in Sejong City, South Korea.
Key people
Chief Executive Officer, Director · since 2024
Vice President · since 2012
Don Seon Gwon
Managing Director
Yong Gi Hong
Managing Director
Managing Director
Jin Yeong Kim
Managing Director
Jin Jun Kim
Managing Director
Jin Wun Lee
Managing Director
Cheol Gyu Choi
Assistant Managing Director
Yeong Sik Gil
Assistant Managing Director
Gwang Yeong Jung
Assistant Managing Director
Dong Myeong Kim
Assistant Managing Director
Gyu Wu Nam
Assistant Managing Director
Byeong Dal Noh
Internal Auditor · since 2013
Jeong Geun Park
Assistant Managing Director
Eon Gyu Yoo
Assistant Managing Director
Director · since 2012
Yi Pyo Hong
Assistant Managing Director · since 2011
Yoshihidae Kanjaki
Director · since 2010
Tomochi Kanjaki
Director
Headquarters & legal address
세종특별자치시 전의면 덕고개길 12-11
콜마홀딩스 주식회사
Sejong Special Autonomous City, 50 30004
KR
콜마홀딩스 주식회사
Sejong Special Autonomous City, 50 30004
KR
Address
12-11, Deokgogae-gil, Jeonui-myeon, Sejong-si
KOLMAR HOLDINGS CO., LTD.
Sejong Special Autonomous City, 50 30004
KR
KOLMAR HOLDINGS CO., LTD.
Sejong Special Autonomous City, 50 30004
KR
Previous name
한국콜마홀딩스 주식회사
Other language
KOLMAR HOLDINGS CO., LTD.
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||